CELU - Celularity Inc. Class A Common Stock

CELU

$1.42 0.05 (-3.40%) Last updated: Oct 13, 2026 18:10

52-Week Range

$1.42

$0.56 $1.42 $2.55

Fundamentals Overview

Celularity Inc. Class A Common Stock is in the middle of its 52-week range with low valuation, trending downward today.

Valuation low

P/B 5.29 P/S 1.85

Risk (Beta)

0.89 — in line vol

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Hold — 35% confidence Risk: Moderate Volatility — Beta 0.89. Diversify and only invest what you can afford to lose.

Pressures (Sell):

Volume below average

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$47.70M

P/E (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

52-Week Range

$0.56 - $2.55

Volume vs Avg

0.14x

14% of avg (Low)

Beta

0.89

About

Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.

Sector: Materials

Headquarters: US

Website: www.celularity.com

Beta: 0.89 (Less volatile than market)

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

Metric	Value
Valuation
P/E (TTM)	N/A
PEG (TTM)	N/A
P/B (TTM)	5.29
P/S (TTM)	1.85
Profitability
ROE (TTM)	N/A
ROA (TTM)	-77.94%
Revenue growth (YoY)	N/A
Net margin (TTM)	-345.45%
Gross margin (TTM)	24.39%
Operating margin (TTM)	-274.53%
Debt to equity (TTM)	4.79

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for CELU.

Loading analyst coverage...

Price target data is not available for this symbol from the current data source.

Stock Grades (Institutions)

No stock grades available for this symbol.

No price targets, ratings snapshot, or grades available for this symbol.